成功接受核苷(酸)类似物治疗的慢性乙型肝炎患者存在残余持续病毒复制的证据
该研究对成功接受核苷(酸)类似物治疗的慢性乙型肝炎患者进行纵向血清样本和横断面肝活检分析,发现6例成功治疗患者中3例存在少量病毒进化证据,变异株表观半衰期约7.42周至无限;7例肝活检中4例肝细胞胞质核衣壳相关松弛环状DNA仍阳性。结论认为即使长期治疗,小部分cccDNA库仍被持续低水平HBV复制补充,而大部分cccDNA库随时间持续存在。
要点
- 成功NA治疗的6例患者中3例检测到少量病毒进化证据
- 变异株表观半衰期估计约7.42周至无限
- 7例肝活检中4例肝细胞胞质核衣壳相关松弛环状DNA仍阳性
核心结论
- 即使经过长期治疗,小部分cccDNA库仍被持续低水平HBV复制不断补充,而大部分cccDNA库随时间持续存在。
研究设计与样本
- 研究获取成功接受核苷(酸)类似物治疗患者的系列纵向血清样本和横断面肝活检组织。
- 采用深度测序枚举血清HBV RNA中的病毒变异株,采用原位杂交直接可视化肝细胞中的病毒复制中间体,并估计每个cccDNA的表观半衰期。
主要发现
- 6例成功治疗患者中3例存在明确的小比例病毒进化证据,尽管绝大多数变异株随时间保持相同或具有相似程度的 divergence。
- 变异株表观半衰期估计约为7.42周至无限。
- 7例肝穿刺活检中4例肝细胞胞质核衣壳相关松弛环状DNA仍呈阳性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic hepatitis B is usually treated with nucleos(t)ide analogues (NAs). However, a cure is rarely achieved, even with years of treatment. Here, we investigated whether viral replication is completely halted and how long covalently closed circular DNA (cccDNA) persists in patients successfully treated with NAs. METHODS: A series of longitudinal serum samples and a collection of cross-sectional liver biopsies were obtained from patients successfully treated with NAs. Viral variants in serum HBV RNA were enumerated by deep sequencing. Viral replication intermediates in hepatocytes were directly visualized by in situ hybridization. The apparent half-life of each cccDNA was estimated. RESULTS: Three of 6 successfully treated patients demonstrated clear evidence of a small proportion of virus evolution, although the overwhelming proportion of variants were identical or possessed a similar degree of divergence through time. The apparent half-life of variants was estimated to be from approximately 7.42 weeks to infinite. Hepatocytes remained positive for cytoplasmic nucleocapsids-associated relaxed circular DNA in 4 of 7 liver needle biopsies. CONCLUSIONS: We conclude that even after prolonged treatment, a small proportion of the cccDNA reservoir is constantly replenished by continued low-level HBV replication, whereas a large proportion of the cccDNA reservoir persists over time.
引用
- Yu T, Zhang M, Zhang H, et al. Evidence of Residual Ongoing Viral Replication in Chronic Hepatitis B Patients Successfully Treated With Nucleos(t)ide Analogues. J Infect Dis. 2023. PMID: 36546708. doi:10.1093/infdis/jiac493
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。